1. Introduction and Definition
- Definition: Meningitis is the inflammation of the leptomeninges (pia and arachnoid mater) with variable involvement of the encephalon.
- Classification:** Acute meningitis is classified by etiology into bacterial (pyogenic), viral (aseptic), fungal, or parasitic. Bacterial meningitis is a medical emergency with high mortality if untreated.
2. Epidemiology and Etiology
The etiological agents vary significantly by age and immune status.
A. Common Etiological Agents
| Age Group / Context | Common Organisms | Remarks |
|---|---|---|
| < 2 years | Streptococcus pneumoniae | Commonest cause; serotypes 6, 1, 19, 14, 5 & 7 prevalent in India. |
| < 3 years | Haemophilus influenzae type b | Incidence reducing due to Hib vaccination. |
| Epidemics / Older Children | Neisseria meningitidis | Serogroups A, B, C, Y, W135. |
| Neonates / Hospital Acquired | E. coli, Klebsiella, Pseudomonas | Associated with prolonged hospital stay or sepsis. |
| Shunts / Head Injury | Staphylococcus (Coag negative/positive) | Associated with VP shunts, trauma, neurosurgery. |
B. Predisposing Factors
- Hematogenous spread: From distant foci (lungs, skin, bones).
- Contiguous spread: Otitis media, mastoiditis, sinusitis.
- Anatomical defects: Neural tube defects, fracture base of skull (CSF rhinorrhea), pilonidal sinus.
- Immunocompromised states: HIV, asplenia (Sickle cell disease), hypogammaglobulinemia, complement deficiency.
3. Pathogenesis
The bacteria typically colonize the nasopharynx and invade the bloodstream.
Sequence of Events:
- Colonization: Nasopharyngeal colonization by organisms.
- Invasion: Cleavage of cell junctions and IgA protease activity allows entry into the bloodstream.
- Bacteremia: Survival in blood (evasion of complement/phagocytosis via capsule).
- CNS Entry: Lodging in the choroid plexus and crossing the blood-brain barrier.
- Inflammation: Bacterial lysis releases cell wall components $\rightarrow$ production of cytokines (IL-1, IL-6, TNF).
- Pathology:
- Cerebral Edema: Vasogenic, cytotoxic, and interstitial.
- Raised ICP: Due to edema and obstructed CSF flow (hydrocephalus).
- Neuronal Damage: Cortical injury from inflammation and ischemia.
4. Clinical Features
Presentation depends on the age of the child and duration of illness.
A. Symptoms
- Constitutional: High-grade fever ($\ge$ 80%), lethargy, irritability, anorexia.
- Raised ICP: Headache (worse in mornings), vomiting (projectile), bulging fontanelle (in infants).
- Neurological: Seizures (1/3rd of patients), altered sensorium (drowsy, stupor, coma), photophobia.
B. Signs of Meningeal Irritation
These may be absent in very young infants or deeply comatose children.
- Neck Rigidity: Resistance to passive neck flexion.
- Kernig’s Sign: Pain/resistance on extending the knee beyond 135° when the hip is flexed to 90°.
- Brudzinski’s Sign: Spontaneous flexion of knees/hips upon passive flexion of the neck.
C. Other Signs
- Skin: Petechiae/purpura (Meningococcemia).
- Neurological Deficits: Focal deficits (10-20%), VI nerve palsy (false localizing sign).
- Fundus: Papilledema is uncommon in acute meningitis; if present, suggests complications like abscess or venous sinus thrombosis.
5. Investigations
Lumbar Puncture (LP) is the gold standard diagnostic test
A. Lumbar Puncture
- Timing: Perform as soon as possible unless contraindicated. Do not delay antibiotics for LP if the patient is unstable.
- Contraindications: Papilledema (raised ICP), infection at LP site, bleeding diathesis, cardio-respiratory instability.
- Procedure: Lateral recumbent position, L3-L4 or L4-L5 space.
B. CSF Analysis (Comparison Table)
| Parameter | Normal | Pyogenic (Bacterial) | Tubercular (TBM) | Viral (Aseptic) |
|---|---|---|---|---|
| Appearance | Clear | Turbid | Clear/Cobweb | Clear |
| Pressure | Normal | Elevated | Elevated | Normal/Mild high |
| Cells | <5 (lymphocytes) | 100–1000s (Neutrophils) | 25–500 (Lymphocytes) | 10–100 (Lymphocytes) |
| Protein (mg/dl) | <40 | High (100–500) | Very High (100–500+) | Normal/Slight high |
| Sugar (mg/dl) | >50 ($\ge$2/3 bld) | Low (<40) | Low (<50) | Normal |
| Stains | Negative | Gram Stain (+ve) | AFB/GeneXpert | Negative |
C. Other Investigations
- Blood: CBC (Leukocytosis), Blood Culture (Positive in 50%), CRP, Electrolytes (SIADH).
- Latex Agglutination: For partially treated cases (detects antigens of Hib, Pneumococcus, Meningococcus).
- Neuroimaging (CT/MRI): Not routine. Indicated for focal signs, persistent fever, suspected abscess, or raised ICP.
6. Management of Acute Bacterial Meningitis
Goal: Rapid sterilization of CSF and control of intracranial pressure.
A. Empiric Antibiotic Therapy
Start immediately after samples are drawn.
| Organism/Age | Antibiotic of Choice | Duration |
|---|---|---|
| Unknown Etiology | Ceftriaxone (100 mg/kg/day) OR Cefotaxime (200 mg/kg/day) | 10 days |
| Pneumococcus | Penicillin G (if sens) OR Ceftriaxone + Vancomycin (60 mg/kg/d) | 10–14 days |
| H. influenzae | Ceftriaxone OR Cefotaxime | 10–14 days |
| Meningococcus | Penicillin G OR Ceftriaxone | 7 days |
| Staphylococcus | Vancomycin + Rifampicin/Linezolid | 28 days |
| Pseudomonas | Ceftazidime + Aminoglycoside | 21 days |
B. Steroid Therapy (Dexamethasone)
- Rationale: Reduces cytokine-mediated inflammation, hearing loss, and neurological sequelae.
- Dose: 0.15 mg/kg/dose IV every 6 hours for 4 days.
- Timing: Must be given 15 minutes before or with the first dose of antibiotics.
- Indication: Strongly recommended for H. influenzae and Pneumococcal meningitis.
C. Supportive Care
- Fluids: Maintenance fluids recommended. Restrict to 2/3rd maintenance only if SIADH is confirmed (Na <120 mEq/L). Avoid hypotonic fluids.
- Raised ICP: Elevate head to 30°. Mannitol (0.25-0.5 g/kg) if signs of herniation. Hyperventilation (maintain pCO2 25-30 mmHg) in ventilated patients.
- Seizures: Treat with IV Benzodiazepines and Phenytoin.
- Vitals: Maintain normothermia, normoglycemia, and adequate perfusion.
7. Complications
Acute (First few days)
- Seizures (early onset <4 days).
- Raised Intracranial Tension / Herniation.
- Shock / DIC (Waterhouse-Friderichsen syndrome).
- Hyponatremia (SIADH).
Subacute/Chronic
- Subdural Effusion: Suspect if persistent fever, increasing head size. Treat only if symptomatic (taps).
- Subdural Empyema: Requires surgical drainage.
- Hydrocephalus: Communicating or obstructive.
- Brain Abscess: Focal deficits, fever.
Sequelae
- Sensorineural Hearing Loss (10-25%).
- Mental Retardation / Developmental Delay.
- Epilepsy.
- Motor deficits (Hemiparesis).
8. Prevention
A. Vaccination
- Hib Vaccine: Dramatically reduced H. flu meningitis (>95% reduction).
- Pneumococcal Conjugate Vaccine (PCV): Prevents invasive pneumococcal disease.
- Meningococcal Vaccine: For epidemics and high-risk groups (>2 yrs).
B. Chemoprophylaxis for Contacts
- Meningococcus: Rifampicin (20 mg/kg/day BD for 2 days) OR Ciprofloxacin (single dose).
- H. influenzae: Rifampicin (20 mg/kg/day OD for 4 days).